Enterprise Value
$328.94 M
+$9.11 M+2.85%
Wed, 27 Nov 2024 23:30:03 GMT
Summary:
Heron Therapeutics enterprise value is currently $328.94 million, with a rise of +$9.11 million (+2.85%) during the most recent trading day. Over the past year, it has dropped by -$14.30 million (-4.17%). HRTX enterprise value is now -89.60% below its all-time high of $3.16 billion.HRTX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +2.9% | +5.4% | +5.4% |
| 1 m1 month | -23.8% | -36.8% | -37.0% |
| 3 m3 months | -26.2% | -38.1% | -38.3% |
| 6 m6 months | -53.1% | -67.5% | -67.8% |
| ytdytd | -19.7% | -31.8% | -32.6% |
| 1 y1 year | -4.2% | -10.9% | -12.1% |
| 5 y5 years | -85.4% | -92.3% | -95.5% |
HRTX Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $448 M | -26.5% | $318 M | +3.3% |
| 3 m | 3 months | $474 M | -30.6% | $318 M | +3.3% |
| 6 m | 6 months | $751 M | -56.2% | $318 M | +3.3% |
| 1 y | 1 year | $751 M | -56.2% | $318 M | +3.3% |
| 3 y | 3 years | $1.08 B | -69.6% | $230 M | +43.1% |
| 5 y | 5 years | $2.35 B | -86.0% | $230 M | +43.1% |
| alltime | all time | $3.16 B | -89.6% | -$12 M | +2815.5% |
Heron Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2024 | $328.94 M(-19.7%) |
| 2023 | $409.44 M(-6.9%) |
| 2022 | $440.00 M(-56.0%) |
| 2021 | $1.00 B(-46.0%) |
| 2020 | $1.85 B(-10.5%) |
| 2019 | $2.07 B(+3.5%) |
| 2018 | $2.00 B(+89.9%) |
| 2017 | $1.05 B(+89.8%) |
| 2016 | $555.05 M(-37.7%) |
| 2015 | $891.07 M(+299.7%) |
| 2014 | $222.95 M(+58.2%) |
| 2013 | $140.89 M(+24.4%) |
| 2012 | $113.21 M(+302.3%) |
| 2011 | $28.14 M(+76.4%) |
| 2010 | $15.96 M(-62.7%) |
| 2009 | $42.73 M(+1310.7%) |
| 2008 | $3.03 M(-80.0%) |
| 2007 | $15.14 M(-53.4%) |
| 2006 | $32.52 M(-14.2%) |
| Date | Value |
|---|---|
| 2005 | $37.89 M(-0.8%) |
| 2004 | $38.19 M(-24.3%) |
| 2003 | $50.47 M(+193.7%) |
| 2002 | $17.18 M(-67.8%) |
| 2001 | $53.39 M(+28.6%) |
| 2000 | $41.50 M(-39.6%) |
| 1999 | $68.76 M(-35.4%) |
| 1998 | $106.46 M(-15.4%) |
| 1997 | $125.85 M(-11.2%) |
| 1996 | $141.69 M(+51.8%) |
| 1995 | $93.36 M(+32.1%) |
| 1994 | $70.67 M(-3.9%) |
| 1993 | $73.55 M(-33.2%) |
| 1992 | $110.04 M(+2.5%) |
| 1991 | $107.40 M(+364.3%) |
| 1990 | $23.13 M(-58.0%) |
| 1989 | $55.09 M(+16.4%) |
| 1988 | $47.31 M(+35.4%) |
| 1987 | $34.95 M |
FAQ
- What is Heron Therapeutics enterprise value?
- What is the all time high enterprise value for Heron Therapeutics?
- What is HRTX enterprise value year-to-date change?
- What is Heron Therapeutics enterprise value year-on-year change?
What is Heron Therapeutics enterprise value?
The current enterprise value of HRTX is $328.94 M
What is the all time high enterprise value for Heron Therapeutics?
Heron Therapeutics all-time high enterprise value is $3.16 B
What is HRTX enterprise value year-to-date change?
Heron Therapeutics enterprise value has changed by -$80.51 M (-19.66%) since the beginning of the year
What is Heron Therapeutics enterprise value year-on-year change?
Over the past year, HRTX enterprise value has changed by -$14.30 M (-4.17%)